期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 147, 期 -, 页码 130-149出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.01.094
关键词
NPP1 inhibitor; Quinazoline; Sulfamide; Calcific aortic valve disease
资金
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Fonds de recherche sur la nature et les technologies (FRQNT)
- FRQNT Research Network on Protein Function, Structure and Engineering (PROTEO)
- Heart and Stroke Foundation of Canada
- Universite Laval
The ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) was recently shown to promote mineralization of the aortic valve, hence, its inhibition represents a significant target. A quinazoline-4. piperidine sulfamide compound (QPS1) has been described as a specific and non-competitive inhibitor of NPP1. We report herein the synthesis and in vitro inhibition studies of novel quinazoline-4-piperidinc sulfamide analogues using QPS1 as the lead compound. Of the 26 derivatives prepared, four compound were found to have K-i < 105 nM against human NPP1. (C) 2018 Elsevier Masson SAS. All rights reserved
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据